<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        ProcessUnity, a provider of comprehensive risk management and cybersecurity solutions, has announced its integration with the Global Risk Exchange (GRX; formerly known as CyberGRX). The company claims that the move to combine its services transforms ProcessUnity into the industry's first all-inclusive risk platform, aiming to modernize third-party risk management (TPRM) initiatives.
      </p>
    </li>
    <li>
      <p>
        ProcessUnity's integrated platform brings together TPRM automation, a universal data core, the Global Risk Exchange, and AI-enabled TPRM teams. These features provide a unified, efficient system for identifying, assessing, monitoring, and controlling third-party-related risks. The company also reported that users have reported substantial reductions in oversight, onboarding, and assessment times.
      </p>
    </li>
    <li>
      <p>
        <b>Analyst QuickTake: </b>
        This integration follows the acquisition of CyberGRX by ProcessUnity in 
        <a href="https://www.processunity.com/processunity-cybergrx-form-most-complete-third-party-risk-management-platform/">
          July 2023
        </a>
        , where the intention was to combine the offerings of the two entities to deliver a standard risk database for vendor assessments and cyber risk data while continuing to provide new solutions for third-party risk management.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.businesswire.com/news/home/20240130885524/en/ProcessUnity-Introduces-Industry%E2%80%99s-All-In-One-Third-Party-Risk-Management-Platform">
      Press release
    </a>
  </p>
  <p>
  </p>
</div>


Supply Chain Tech

ANALYST_QUICK_TAKE

PROMINENT_CATEGORY

<div>
 
 <p>ProcessUnity, a risk management and cybersecurity solutions provider, has integrated with the Global Risk Exchange (GRX), formerly CyberGRX. The company claims this integration makes ProcessUnity the first all-inclusive risk platform in the industry, aimed at modernizing third-party risk management (TPRM) initiatives.</p>
 <p>The integrated platform includes TPRM automation, a universal data core, the Global Risk Exchange, and AI-enabled TPRM teams, enabling a unified system for handling third-party risks. Users have reportedly seen significant reductions in oversight, onboarding, and assessment times.</p>

</div> <p><b>Analyst QuickTake: </b> This integration follows the acquisition of CyberGRX by ProcessUnity in <a href="https://www.processunity.com/processunity-cybergrx-form-most-complete-third-party-risk-management-platform/"> July 2023 </a> , where the intention was to combine the offerings of the two entities to deliver a standard risk database for vendor assessments and cyber risk data while continuing to provide new solutions for third-party risk management.</p>

ProcessUnity integrates GRX to deliver enhanced third-party risk management

A decentralized version of the web powered by the blockchain

Web3 Ecosystem

<div>
 
 <p>Polkadot development tool kit platform, Apillon, recently introduced an Embedded Wallet SDK on the Oasis Network. This simple Web3 login tool empowers users to connect to EVM-compatible blockchain using conventional login credentials.</p>
 <p>Integrated directly into decentralized applications (dApps), the Embedded Wallet allows logins via email, passkeys, and social accounts. It employs confidential smart contracts to encrypt and store user data and private keys. Moreover, it securely handles transactions and confidential data within the Oasis Network's privacy-focused blockchain ecosystem.</p>
 <p>The tool achieves a balance between the simplicity of Web2 and the security of Web3, according to Apillon. It renders the understanding of private keys or seed phrases unnecessary and provides enhanced recovery solutions to minimize the risk of losing access to digital assets.</p>
 <p>Apillon, founded in 2021, is a Web3 development platform providing developers access to unified API endpoints to create and launch blockchain-based projects within the Polkadot ecosystem. It accommodates multiple programming languages and offers tools such as SDKs, CLIs, and relevant documentation to aid developers design NFTs, GameFi, DeFi, and other Web3 applications.</p>
 
</div>

Apillon launches embedded wallet SDK for Web3 login

Technologies bringing about a new reality

Extended Reality

INCUMBENTS_PRESENT

<div>
    <p>Meta has extended its partnership with the National Basketball Association (NBA) to offer live streaming of 52 NBA games in virtual reality (VR) for the 2024–2025 season on Meta's Quest headsets. The games will be broadcasted on the Xtadium and NBA Arena apps within the Meta Horizon Worlds, aiming to create an immersive gaming experience.</p>
    <p>Quest users can experience the games as if they were physically present at the stadium, thanks to a spatial sound system. Additional features include accessibility to game highlights, real-time statistics, ability to play mini-games, and interaction with friends within the virtual stadium.</p>
    <p>Meta, formerly Oculus, became the NBA's official VR platform in 2020. This partnership also covers the Women's NBA (WNBA) and the NBA's development league, the G-League.</p>
</div> <p><b>Analyst QuickTake:<br>
 </b> Meta's Meta's partnership with the NBA to deliver live VR basketball games builds on the league's <a href="https:<br>
//sp-edge.com/updates/23257"> 2023 expansion </a> of 180-degree immersive match recordings for NBA League Pass subscribers on Meta's Horizon Worlds and Xtadium app. This collaboration, alongside a similar one with <a href="https:<br>
//www.sportspromedia.com/broadcast-ott/media-rights/espn-meta-quest-vr-sport-horizon-worlds-xstadium/"> ESPN </a> for immersive broadcasts on the Meta Quest platform, is key for enhancing user engagement and adopting Meta's VR technology.</p>

Meta extends NBA partnership to bring live VR basketball games to Quest users

The toolkit to build machine learning applications at scale

Machine Learning Infrastructure

<div>
 <p>Kneron, an AI chip manufacturer, aims to raise USD 300 million in its latest funding round, potentially bringing its evaluation to USD 1 billion. The company has received investments from Qualcomm Ventures, Sequoia Capital China (now HongShan), Hon Hai Precision Industry Co., and Horizons Ventures in the past.<p>
  
<p>With this new funding, Kneron plans to fuel product innovation and expansion plans that include establishing a regional office and an R&D lab in Saudi Arabia. The round is likely to be its last before the company's expected public listing in 2025.</p>
 
</div> <p><b>Analyst QuickTake:<br>
</b> The surging demand for AI chips has helped Kneron to raise significantly more funding than its USD 49 million Series B funding raised in <a href="https:<br>
//sp-edge.com/updates/22177"> September 2023 </a> . Additionally, funding proceeds from last year helped the company launch its new KNEO 330 AI chip for on-premise AI applications in <a href="https:<br>
//sp-edge.com/updates/30098"> June 2024 </a> .</p>

AI chip maker Kneron seeks USD 300 million in funding from investors

Empowering Tomorrow's Innovations with Generative AI Infrastructure

Generative AI Infrastructure

<div>
 <p>AI chip manufacturer Kneron is reportedly seeking to raise approximately USD 300 million in a new funding round. This significant investment would place the value of the Taiwanese-American company at an estimated USD 1 billion. In the previous funding rounds, Kneron received support from renowned investors such as Qualcomm Ventures, Sequoia Capital China (now known as HongShan), Hon Hai Precision Industry Co., and Horizons Ventures.</p>
 <p>Kneron plans on allocating the funds towards the advancement of product innovation and company expansion. One of the company's more specific objectives include the creation of a regional office and a research &amp; development lab located in Saudi Arabia. This fundraising is projected to be the final private round for Kneron, as it plans to pursue a public listing in 2025.</p>
</div> <p><b>Analyst QuickTake:<br>
</b> The surging demand for AI chips has helped Kneron to raise significantly more funding than its USD 49 million Series B funding raised in <a href="https:<br>
//sp-edge.com/updates/22177"> September 2023 </a> . Additionally, funding proceeds from last year helped the company launch its new KNEO 330 AI chip for on-premise AI applications in <a href="https:<br>
//sp-edge.com/updates/30098"> June 2024 </a> .</p>

Retail investors demanding sophisticated passive investment strategies are looking for an edge.

Retail Trading Infrastructure

<div>
 
 <p>Moneybox, a UK-based investing and savings platform, has garnered GBP 70 million (~USD 90.5 million) from a secondary funding round headed by Apis Global Growth Fund III and including Amundi. This funding round has raised the company's value to GBP 550 million, reflecting an 84% rise since its Series D valuation in March 2022.</p>
 <p>The funds will be raised via a sale of secondary shares, with present investors offloading around 10%–15% of their existing share capital. This allows the company's 35,000 shareholders, such as crowdfund investors, clients, and staff, to sell off 10% of their shares.</p>
 <p>With over GBP 10 billion in assets under administration (AUA), Moneybox has moved into profitability. The firm reported a 168% surge in revenue and a 46% rise in AUA per client in the previous fiscal year, offering its services to over a million customers throughout the UK.</p>
 
</div>

Moneybox raises GBP 70 million in secondary funding from Apis Growth Fund III

Exploring the limitless possibilities of AI

Generative AI Applications

<div>
 <p>A lawsuit claims wrongful death, negligence, deceptive trade practices, and product liability against Character.AI, its founders, and Google over the death of a 14-year-old. It argues that Character.AI's AI chatbot platform, including those focused on mental health, were inadequately safe and marketed to children. The teen had been in frequent interaction with several chatbots prior to his death on February 28, 2024.</p>
 <p>Character.AI has now introduced several safety enhancements, such as adjusting the AI models for minors, improving violation detection, updating disclaimers, and implementing session time notifications in response to the suit.</p>
</div>

Lawsuit filed against Character.AI and Google claiming lack of safety guardrails

<div>
 <p>Google has launched SynthID Text, a tool for identifying and watermarking AI-generated text. It is freely available to download from Hugging Face and Google's Responsible GenAI Toolkit for developers and businesses. </p>
 <p>The technology functions by adjusting the probability scores of tokens during the process of text generation, thereby developing a distinct watermark pattern. This pattern allows the detection of AI-generated text based on the modified word choices and probability scores.</p>
</div> <p><b>Analyst QuickTake:<br>
 </b> As AI-generated content becomes more prevalent, the potential for misuse and confusion increases. Watermarking provides a method for identifying text's origin, helping users discern between human-written and AI-generated materials. This initiative reflects a growing awareness of the ethical implications of AI in content creation. By implementing watermarking, Google aims to enhance transparency and trust in digital communications. It may also encourage other companies to adopt similar practices, encouraging a broader industry standard for identifying AI-generated content.</p>

Google open-sources watermarking tool 'SynthID Text'

<div>
 <p>Apple has introduced the initial developer beta for iOS 18.2, encompassing advancements like new AI characteristics and ChatGPT integration. The update is being made accessible to developers via iOS 18.2, iPadOS 18.2, and macOS 15.2 beta versions.</p>
 <p>The upgrade consists of multiple novel AI-activated attributes: Image Playground for generating custom images from text prompts, Genmoji for engineering personalized emojis, Image Wand that transforms sketches to polished images, upgraded Writing Tools featuring ChatGPT integration, and Visual Intelligence available to iPhone 16 users which assists them in learning about their surroundings through the camera.</p>
 <p>Apple is broadening the application of Apple Intelligence beyond the US into the English-speaking regions such as UK, Canada, Australia, South Africa, and New Zealand. Nonetheless, regulatory limitations make these features inaccessible in China and the EU. The iOS 18.2 is projected to be publicly released by year-end.</p>
</div> <p><b>Analyst QuickTake:<br>
 </b> This move aligns with the growing trend of incorporating AI into everyday applications, reflecting Apple's commitment to staying competitive in the tech landscape. By leveraging ChatGPT, Apple aims to improve its ecosystem, potentially improving functionalities across its devices and services, from Siri to productivity tools. This integration could enhance natural language processing, making interactions more intuitive and efficient for users.</p>

Apple releases iOS 18.2 beta with AI features and ChatGPT integration

Artificial intelligence is identifying and testing new therapies faster than ever.

AI Drug Discovery

<div>
 
 <p>Bioinformatics startup Proscia is collaborating with French AI firm Bioptimus to incorporate Bioptimus's H-optimus-0 foundation model into Proscia's Concentriq Embeddings platform. The model, having 1.1 billion parameters, is set to hasten AI development in life sciences and pathology. This integration will enhance the use of datasets for pathology-related AI development, consequently improving therapeutic development for organizations.</p>
 
</div>

Proscia and Bioptimus partner to accelerate AI innovation in scientific research and drug development

Leveraging personal data for custom-fit diagnosis and treatment

Precision Medicine

<div>

 <p>Allarity Therapeutics has secured preliminary approval from the European Patent Office for its drug response predictor (DRP) intended for use with Pfizer's cancer treatment, stenoparib.</p>
 <p>The companion diagnostic tool of DRP uses gene expression profiles to pinpoint patients who are most likely to respond positively to Stenoparib, with the goal of improving the therapy's success rate. Stenoparib is an orally-taken small molecule that simultaneously targets PARP1/2 and Tankyrase 1 and 2.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> Stenoparib was developed by Allarity Therapeutics in collaboration with Oncoheores, which was initiated in <a href="https:<br>
//sp-edge.com/updates/7551"> January 2022 </a> . The agreement stated that Oncoheroes would be granted exclusive worldwide rights for Dovitinib and Stenoparib, aimed at treating pediatric cancer patients, offering Allarity an undisclosed upfront licensing fee and regulatory milestone payment. Oncoheroes agreed to conduct clinical trials for the two drugs, while Allarity supported the development of companion diagnostic tests to screen pediatric patients for treatment eligibility.</p>

All Updates

ProcessUnity integrates GRX to deliver enhanced third-party risk management

Apillon launches embedded wallet SDK for Web3 login

Meta extends NBA partnership to bring live VR basketball games to Quest users

AI chip maker Kneron seeks USD 300 million in funding from investors

AI chip maker Kneron seeks USD 300 million in funding from investors

Moneybox raises GBP 70 million in secondary funding from Apis Growth Fund III

Lawsuit filed against Character.AI and Google claiming lack of safety guardrails

Google open-sources watermarking tool 'SynthID Text'

Apple releases iOS 18.2 beta with AI features and ChatGPT integration

Proscia and Bioptimus partner to accelerate AI innovation in scientific research and drug development

Allarity Therapeutics receives European patent for Stenoparib DRP diagnostic test

Supply Chain Tech

ProcessUnity integrates GRX to deliver enhanced third-party risk management

Contact us